People: ImmunoGen Inc (IMGN.OQ)

IMGN.OQ on NASDAQ Stock Exchange Global Select Market

10.69USD
11:04am EDT
Price Change (% chg)

$-0.42 (-3.78%)
Prev Close
$11.11
Open
$10.98
Day's High
$11.01
Day's Low
$10.64
Volume
49,137
Avg. Vol
302,961
52-wk High
$20.24
52-wk Low
$10.32

Search Stocks

Peterson, Kristine 

Brief Biography

Ms. Kristine Peterson has been appointed as Independent Director of ImmunoGen, Inc., effective January 30, 2012. Ms. Peterson has served as Chief Executive Officer of Valeritas, Inc., a medical technology company focusing on innovative drug delivery systems, since 2009. Prior to that she served as Company Group Chair of Johnson & Johnson's biotech groups from 2006 to 2009, and as Executive Vice President for J&J's global strategic marketing organization from 2004 to 2006. Prior to that she served as Senior Vice President, Commercial Operations for Biovail Corporation, a pharmaceutical company, and President of Biovail Pharmaceuticals from 2003 to 2004. Prior to that she spent 20 years at Bristol-Myers Squibb Company, a pharmaceutical company, in assignments of increasing responsibility spanning marketing, sales and general management, including running a cardiovascular/metabolic business unit and a generics division. Ms. Peterson is also a director of Amarin Corporation plc and Valeritas, Inc. We believe that Ms. Peterson's qualifications to serve on our Board include her extensive executive management and sales and marketing experience in both mature pharmaceutical and smaller biotechnology companies, in particular as it relates to later-stage development and commercialization, and her other public company board experience.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Stephen McCluski

--

Daniel Junius

2,384,580

David Johnston

--

Ellie Harrison

--

John Lambert

1,427,110

Charles Morris

2,560,080
As Of 29 Jun 2013
Search Stocks